The use of a decision support system will increase adherence to the ESC guideline for atrial fibrillation in terms of calculation of bleeding and stroke risk, and accurate anti-thrombotic treatment for stroke prevention.
ID
Bron
Aandoening
Atrial Fibrillation, Prevention, Stroke, Bleeding, Anticoagulants
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The proportion of patients with atrial fibrillation whose anti-thrombotic treatment is in accordance with the ESC guideline for atrial fibrillation.
Achtergrond van het onderzoek
A decision support system will be implemented in the cardiologists EHR. This system will calculate the bleeding and stroke risk of patients (CHA2DS2-VASc score and HAS-BLED score), triggered by entering the diagnosis atrial fibrillation in the EHR. The system calculates the risk scores based on values already available in the EHR, and advices on antithrombotic treatment in terms of OAC/NOAC.
Our main outcomes will be the percentage of accurate anti thrombotic prescriptions in patients with atrial fibrillation according to the ESC guideline for atrial fibrillation.
Doel van het onderzoek
The use of a decision support system will increase adherence to the ESC guideline for atrial fibrillation in terms of calculation of bleeding and stroke risk, and accurate anti-thrombotic treatment for stroke prevention.
Onderzoeksopzet
Data of each patient visiting the cardiologist for AF are saved automatically. Adherence is measured at the end of the study.
Onderzoeksproduct en/of interventie
The decision support system is implemented within the electronic health record (EHR) of a patient. When entering the diagnoses atrial fibrillation in the EHR of the patient, the system calculates the risk of stroke (CHA2DS2-VASc score) and the risk of bleeding (HAS-BLED score) based on the values entered/saved in the EHR. Furthermore, based on the calculated bleeding and stroke risk, a medication advice is given in terms of OAC/NOAC.
The intervention arm received the embedded decision support withing the EHR, whereas the control arm uses the EHR without the decision support system.
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients: All patients with atrial fibrillation visiting the cardiologist of one of the three selected hospitals.
Cardiologists: All cardiologists working at one of the three selected hospitals in the Netherlands
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
N/A
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL4768 |
| NTR-old | NTR5011 |
| Ander register | : ExpertAF-EHR |